Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 3509-3513, June 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roossien, F. F.
Right arrow Articles by Roos, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Roossien, F. F.
Right arrow Articles by Roos, E.

Invasive and Metastatic Capacity of Revertants of LFA-1-deficient Mutant T-Cell Hybridomas

Folkert F. Roossien1, Patricia E. de Kuiper, Diana de Rijk1 and Ed Roos2

Division of Cell Biology, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), 121 Plesmanlaan, 1066 CX Amsterdam, The Netherlands

From the highly metastatic TAM2D2 T-cell hybridoma we have previously generated three independent mutants that were deficient in the surface expression of the adhesion molecule Leukocyte Function-associated Antigen 1 (LFA-1). Both the invasive capacity and the metastatic potential of these mutants were greatly reduced compared with TAM2D2 cells (F. F. Roossien et al., J. Cell Biol., 108: 1979–1985, 1989). We now show that, during in vivo transplantation, LFA-1 is reinduced in these mutants. From such revertant cell populations obtained after two to three i.p. passages, we isolated clones with different LFA-1 levels. Of each of the three mutant cell lines, the clone with the highest and the one with the lowest LFA-1 level were selected for further study. Invasiveness in fibroblast monolayers correlated strongly with LFA-1 level; i.e., the low-LFA-1 clones (mean LFA level, approximately 10% of TAM2D2) invaded as poorly as the original mutants, whereas the high-LFA-1 clones (>25% of TAM2D2) were highly invasive. Metastatic potential was determined after tail vein injection of 106 cells in syngeneic AKR mice. A difference was observed between high- and low-LFA-1 clones, albeit less striking than previously found between LFA-1-negative mutants and parental TAM2D2 cells. The high-LFA-1 clones developed metastases in more mice (76 versus 43%) and earlier (mean survival, 30 versus 37 days). These results provide further evidence for an important role of LFA-1 in invasion and metastasis of mouse T-cell hybridomas.

1 Supported by Grant NKI 85-6 from the Dutch Cancer Society.

2 To whom requests for reprints should be addressed.

Received 7/20/89. Revised 2/ 7/90.


This article has been cited by other articles:


Home page
BloodHome page
S. D. Belanger and Y. St-Pierre
Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma
Blood, June 15, 2005; 105(12): 4800 - 4806.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.